Fair Value (Tables)
|
12 Months Ended |
Dec. 31, 2022 |
Fair Value Disclosures [Abstract] |
|
Fair value measurement inputs and valuation techniques |
Following are descriptions of the valuation methodologies used to measure material assets and liabilities at fair value and the details of the valuation models, key inputs to those models and significant assumptions utilized. Within the assumption tables presented, not meaningful ("NM") refers to a range of inputs that is too broad to provide meaningful information to the user or to an input that has no range and consists of a single data point.
|
|
|
|
|
|
|
|
|
|
|
|
Instrument |
Valuation techniques |
Classification of Fair Value Hierarchy |
Assets |
Loans held for investment, subject to HMBS related obligations(1)
|
|
HECM loans - securitized into Ginnie Mae HMBS |
These loans are valued utilizing a present value methodology that discounts estimated projected cash flows over the life of the loan portfolio using conditional prepayment rate ("CPR"), loss frequency and severity, borrower mortality, borrower draw, and discount rate assumptions. |
Level 3 |
Loans held for investment, subject to nonrecourse debt(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
HECM buyouts - securitized (nonperforming) |
These loans are valued utilizing a present value methodology that discounts estimated projected cash flows over the life of the portfolio using conditional repayment rate, loss frequency, loss severity, and discount rate assumptions. |
Level 3 |
|
HECM buyouts - securitized (performing) |
These loans are valued utilizing a present value methodology that discounts estimated projected cash flows over the life of the portfolio using weighted average remaining life, conditional repayment rate, loss severity, and discount rate assumptions. |
Level 3 |
|
Non-agency reverse mortgage - securitized |
These loans are valued utilizing a present value methodology that discounts estimated projected cash flows over the life of the portfolio using weighted average remaining life, loan to value, conditional repayment rate, loss severity, home price appreciation, and discount rate assumptions. |
Level 3 |
|
Fix & flip mortgage loans |
This product is valued using a discounted cash flow model utilizing prepayment rate (single monthly mortality or "SMM"), discount rate, and loss rate assumptions. |
Level 3 |
(1) The Company aggregates loan portfolios based upon the underlying securitization trust and values these loans using these aggregated pools. The range of inputs provided are based upon the range of inputs utilized for each securitization trust.
|
Loans held for investment |
|
Inventory buy-outs |
The fair value of repurchased loans is based on expected cash proceeds of the liquidation of the underlying properties and expected claim proceeds from HUD. The primary assumptions utilized in valuing nonperforming repurchased loans include conditional prepayment rate, loss frequency, loss severity, and discount rate.
Termination proceeds are adjusted for expected loss frequencies and severities to arrive at net proceeds that will be provided upon final resolution, including assignments to FHA. Historical experience is utilized to estimate the loss rates resulting from scenarios where FHA insurance proceeds are not expected to cover all principal and interest outstanding and, as servicer, the Company is exposed to losses upon resolution of the loan.
|
Level 3 |
|
Non-agency reverse mortgage |
The fair value of non-agency reverse mortgage loans is based on values for investments with similar investment grade ratings and the value the Company would expect to receive if the whole-loans were sold to an investor.
The Company values non-agency reverse mortgage loans utilizing a present value methodology that discounts estimated projected cash flows over the life of the loan portfolio. The primary assumptions utilized in valuing the loans include loan to value, conditional prepayment rate, loss severity, home price appreciation, and discount rate.
|
Level 3 |
|
Fix & flip mortgage loans |
This product is valued using a DCF model with prepayment rate (SMM), discount rate, and loss rate assumptions. |
Level 3 |
|
Agricultural loans |
The product is valued using a DCF model with discount rate, prepayment rate, and default rate assumptions. |
Level 3 |
Loans held for sale |
|
Residential mortgage loans |
Loans valued using observable market prices for identical or similar assets – This includes all mortgage loans that can be sold to the Agencies, which are valued predominantly by published forward agency prices. This will also include all non-agency loans where recently negotiated market prices for the loan pool exist with a counterparty (which approximates fair value), or quoted market prices for similar loans are available.
|
Level 2 |
|
|
|
|
|
Single Rental Loan ("SRL") |
This product is valued using a DCF model utilizing prepayment rate (CPR), discount rate, and constant default rate ("CDR") assumptions. |
Level 3 |
|
Portfolio loans |
This product is valued using a DCF model utilizing prepayment rate (CPR), discount rate, and default rate (CDR) assumptions. |
Level 3 |
Mortgage Servicing Rights |
|
|
|
|
|
|
|
|
|
|
|
|
|
MSR |
The Company valued MSR internally through a DCF analysis and calculated using a pricing model. This pricing model is based on the objective characteristics of the portfolio (loan amount, note rate, etc.) and commonly used industry assumptions such as discount rate and weighted average prepayment speed (CPR). |
Level 3 |
Derivative assets/liabilities |
|
IRLCs |
The fair value is derived from the fair value of similar mortgage loans or bonds, which is based on observable market data. Changes to the fair value of IRLCs are recognized based on changes in interest rates, changes in the probability that the commitment will be exercised (pull through rate), and the passage of time. The expected net future cash flows related to the associated servicing of the loan are included in the fair value measurement of IRLCs. |
Level 3 |
|
Loan purchase commitments ("LPCs") |
This product is valued based on current market prices for HMBS. |
Level 2 |
|
Forward MBS and TBAs |
This product is valued using forward dealer marks from the Company's approved counterparties, forward prices with dealers in such securities, or internally-developed third party models utilizing observable market inputs |
Level 2 |
|
Interest rate swaps and futures contracts |
This product is valued using quoted market prices |
Level 1 |
Other assets |
|
|
|
|
|
Retained bonds |
Management obtains third party valuations to assess the reasonableness of the fair value calculations provided by the internal valuation model. The primary assumptions utilized include weighted average life remaining and discount rate. |
Level 3 |
|
Investments |
To the extent market prices are not observable, the Company engages third party valuation experts to assist in determining the fair value of these investments. The values are determined utilizing a market approach which estimates fair value based on what other participants in the market have paid for reasonably similar assets that have been sold within a reasonable period from the valuation date. |
Level 3 |
|
Purchase Commitments - reverse mortgage loans |
Purchase commitments are valued based on the value of the underlying loan. These loans are valued based on an expected margin on sale of 3.00%. |
Level 3 |
Liabilities |
HMBS related obligations |
|
HMBS related obligations |
The estimated fair value is based on the net present value of projected cash flows over the estimated life of the liability. The estimated fair value of the HMBS related obligations also includes the consideration required by a market participant to transfer the HECM and HMBS servicing obligations, including exposure resulting from shortfalls in FHA insurance proceeds, as well as, assumptions that it believes a market participant would consider in valuing the liability, including, but not limited to, assumptions for repayment, costs to transfer servicing obligations, shortfalls in FHA insurance proceeds, and discount rates. The significant unobservable inputs used in the measurement include conditional borrower repayment rates and discount rates. |
Level 3 |
Nonrecourse debt |
|
Reverse mortgage loans |
The estimated fair value is based on the net present value of projected cash flows over the estimated life of the liability. The significant unobservable inputs used in the measurement include weighted average life remaining, conditional repayment rates, and discount rates. |
Level 3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonrecourse commercial loan financing liability |
The estimated fair value is based on the net present value of projected cash flows over the estimated life of the liability.
The primary assumptions utilized include weighted average life remaining, weighted average prepayment speed (SMM), and discount rates. The Company estimates prepayment speeds giving consideration that the Company may in the future transfer additional loans to the trust, subject to the availability of funds provided for within the trust.
|
Level 3 |
|
Nonrecourse MSR financing liability |
Consistent with the underlying MSR, fair value is derived through a DCF analysis and calculated using a pricing model. This pricing model is based on the objective characteristics of the portfolio (loan amount, note rate, etc.) and commonly used industry assumptions including weighted average prepayment speed (CPR) and discount rate. |
Level 3 |
Deferred purchase price liabilities |
|
Deferred purchase price liabilities |
These are measured using a present value of future payments utilizing discount rate assumptions. |
Level 3 |
|
TRA obligation |
The fair value is derived through the use of a DCF model. The significant unobservable assumptions used in the DCF include the ability to utilize tax attributes based on current tax forecasts, a constant U.S. federal income tax rate, and a discount rate. |
Level 3 |
Warrant liability |
|
Warrants |
The warrants are publicly traded and are valued based on the closing market price of the applicable date of the Consolidated Statements of Financial Condition. |
Level 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2022 |
|
December 31, 2021 |
Instrument / Unobservable Inputs |
|
Range |
|
Weighted Average |
|
Range |
|
Weighted Average |
Assets |
Loans held for investment, subject to HMBS related obligations |
|
Conditional repayment rate |
|
NM |
|
21.9
|
% |
|
NM |
|
20.8 |
% |
|
Loss frequency |
|
NM |
|
4.1
|
% |
|
NM |
|
4.5 |
% |
|
Loss severity |
|
2.4% - 12.1% |
|
2.7
|
% |
|
3.1% - 7.7% |
|
3.3 |
% |
|
Discount rate |
|
NM |
|
5.0
|
% |
|
NM |
|
2.4 |
% |
|
Average draw rate |
|
NM |
|
1.1
|
% |
|
NM |
|
1.1 |
% |
Loans held for investment, subject to nonrecourse debt: |
|
HECM buyouts - securitized (nonperforming) |
|
|
|
|
|
Conditional repayment rate |
|
NM |
|
39.2
|
% |
|
NM |
|
41.2 |
% |
|
Loss frequency |
|
23.1% - 100.0% |
|
51.7
|
% |
|
25.0% - 100% |
|
59.5 |
% |
|
Loss severity |
|
2.4% - 12.1% |
|
5.2
|
% |
|
3.1% - 7.7% |
|
4.3 |
% |
|
Discount rate |
|
NM |
|
8.7
|
% |
|
NM |
|
4.1 |
% |
|
HECM buyouts - securitized (performing) |
|
|
|
|
|
Weighted average remaining life (in years) |
|
NM |
|
8.0 |
|
NM |
|
9.0 |
|
Conditional repayment rate |
|
NM |
|
15.2
|
% |
|
NM |
|
13.3 |
% |
|
Loss severity |
|
2.4% - 12.1% |
|
4.8
|
% |
|
3.1% - 7.7% |
|
7.7 |
% |
|
Discount rate |
|
NM |
|
8.2
|
% |
|
NM |
|
3.7 |
% |
|
Non-agency reverse mortgage loans - securitized |
|
|
|
Weighted average remaining life (in years) |
|
NM |
|
9.7 |
|
NM |
|
7.5 |
|
Loan to value |
|
0.0% - 74.7% |
|
43.1
|
% |
|
0.1% - 64.7% |
|
43.4 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2022 |
|
December 31, 2021 |
Instrument / Unobservable Inputs |
|
Range |
|
Weighted Average |
|
Range |
|
Weighted Average |
|
Conditional repayment rate |
|
NM |
|
14.3
|
% |
|
NM |
|
18.6 |
% |
|
Loss severity |
|
NM |
|
10.0
|
% |
|
NM |
|
10.0 |
% |
|
Home price appreciation |
|
(10.1)% - 7.3% |
|
3.8
|
% |
|
(4.6)% - 14% |
|
4.7 |
% |
|
Discount rate |
|
NM |
|
7.1
|
% |
|
NM |
|
3.6 |
% |
|
Fix & flip mortgage loans - securitized |
|
|
|
|
|
|
|
Prepayment rate (SMM) |
|
NM |
|
11.2
|
% |
|
NM |
|
14.1 |
% |
|
Discount rate |
|
NM |
|
17.5
|
% |
|
NM |
|
5.7 |
% |
|
Loss rate |
|
NM |
|
0.5
|
% |
|
NM |
|
0.6 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2022 |
|
December 31, 2021 |
Instrument / Unobservable Inputs |
|
Range |
|
Weighted Average |
|
Range |
|
Weighted Average |
Loans held for investment: |
|
Inventory buy-outs |
|
|
|
|
|
|
|
|
|
Conditional repayment rate |
|
NM |
|
41.3
|
% |
|
NM |
|
43.2 |
% |
|
Loss frequency |
|
NM |
|
47.6
|
% |
|
NM |
|
59.4 |
% |
|
Loss severity |
|
2.4% - 12.1% |
|
5.6
|
% |
|
3.1% - 7.7% |
|
3.8 |
% |
|
Discount rate |
|
NM |
|
8.7
|
% |
|
NM |
|
4.1 |
% |
|
Non-agency reverse mortgage loans |
|
|
|
|
|
|
|
|
|
Weighted average remaining life (in years) |
|
NM |
|
12.0 |
|
NM |
|
9.2 |
|
Loan to value |
|
0.1% - 67.9% |
|
36.4
|
% |
|
0.2% - 68.7% |
|
47.8 |
% |
|
Conditional repayment rate |
|
NM |
|
13.8
|
% |
|
NM |
|
14.8 |
% |
|
Loss severity |
|
NM |
|
10.0
|
% |
|
NM |
|
10.0 |
% |
|
Home price appreciation |
|
(10.1)% - 7.3% |
|
3.6
|
% |
|
(4.6)% - 14.0% |
|
4.4 |
% |
|
Discount rate |
|
NM |
|
7.1
|
% |
|
NM |
|
3.6 |
% |
|
Fix & flip mortgage loans |
|
|
|
|
|
|
|
Prepayment rate (SMM) |
|
NM |
|
9.5
|
% |
|
NM |
|
11.9 |
% |
|
Discount rate |
|
16.3% - 25.8% |
|
16.6
|
% |
|
5.7% - 10.0% |
|
5.9 |
% |
|
Loss rate |
|
NM |
|
0.2
|
% |
|
NM |
|
0.4 |
% |
|
Agricultural loans |
|
|
|
|
|
|
|
|
|
Discount rate |
|
NM |
|
9.7
|
% |
|
NM |
|
4.8 |
% |
|
Prepayment rate (SMM) |
|
11.0% - 100.0% |
|
11.8
|
% |
|
9.0% - 100.0% |
|
22.1 |
% |
|
Default rate (CDR) |
|
0.0% - 1.0% |
|
0.9
|
% |
|
0.0% - 0.9% |
|
0.9 |
% |
|
|
|
|
|
|
|
|
|
|
Loans held for sale: |
|
SRL |
|
|
|
|
|
|
|
|
|
Prepayment rate (CPR) |
|
18.5% - 25.0% |
|
19.7
|
% |
|
1.0% - 17.1% |
|
14.2 |
% |
|
Discount rate |
|
NM |
|
8.3
|
% |
|
NM |
|
3.3 |
% |
|
Default rate (CDR) |
|
NM |
|
1.0
|
% |
|
1.0% - 57.2% |
|
2.2 |
% |
|
Portfolio loans |
|
|
|
|
|
|
|
|
|
Prepayment rate (CPR) |
|
0.0% - 24.3% |
|
18.4
|
% |
|
0.0% - 14.5% |
|
8.7 |
% |
|
Discount rate |
|
NM |
|
10.9
|
% |
|
NM |
|
3.9 |
% |
|
Default rate (CDR) |
|
NM |
|
1.0
|
% |
|
1.0% - 54.0% |
|
3.2 |
% |
|
|
|
|
|
|
|
|
|
|
Mortgage Servicing Rights |
|
Weighted average prepayment speed (CPR) |
|
1.0% - 8.5% |
|
6.4
|
% |
|
0.0% - 12.8% |
|
8.3 |
% |
|
Discount rate |
|
NM |
|
10.1
|
% |
|
NM |
|
8.5 |
% |
|
|
|
|
|
|
|
|
|
|
Derivative assets/liabilities |
|
IRLCs |
|
|
|
|
|
|
|
|
|
Pull through rate |
|
NM |
|
91.4
|
% |
|
NM |
|
88.1 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2022 |
|
December 31, 2021 |
Instrument / Unobservable Inputs |
|
Range |
|
Weighted Average |
|
Range |
|
Weighted Average |
Other assets: |
|
Retained bonds |
|
|
|
|
|
|
|
|
|
Weighted average remaining life (in years) |
|
2.4 - 24.1 |
|
4.9 |
|
2.6 - 25.0 |
|
5.1 |
|
Discount rate |
|
(16.8)% - 12.2% |
|
6.9
|
% |
|
1.9% - 8.2% |
|
2.7 |
% |
|
|
|
|
|
|
|
|
|
|
Liabilities |
HMBS related obligations |
|
Conditional repayment rate |
|
NM |
|
21.8
|
% |
|
NM |
|
20.8 |
% |
|
Discount rate |
|
NM |
|
5.0
|
% |
|
NM |
|
2.3 |
% |
|
|
|
|
|
|
|
|
|
|
Nonrecourse debt: |
|
Reverse mortgage loans |
|
|
|
|
|
|
|
|
|
Performing/Nonperforming HECM securitizations |
|
|
|
|
|
|
|
Weighted average remaining life (in years) |
|
1.5 - 1.6 |
|
1.6 |
|
0.2 - 0.8 |
|
0.5 |
|
Conditional repayment rate |
|
19.9% - 22.2% |
|
21.1
|
% |
|
30.8% - 54.4% |
|
43.5 |
% |
|
Discount rate |
|
NM |
|
8.6
|
% |
|
NM |
|
2.3 |
% |
|
Securitized non-agency reverse |
|
|
|
|
|
|
|
|
|
Weighted average remaining life (in years) |
|
0.2 - 11.7 |
|
6.4 |
|
1.0 - 2.3 |
|
1.6 |
|
Conditional repayment rate |
|
8.3% - 46.1% |
|
16.5
|
% |
|
18.4% - 35.9% |
|
28.2 |
% |
|
Discount rate |
|
NM |
|
7.2
|
% |
|
NM |
|
2.2 |
% |
|
Nonrecourse commercial loan financing liability |
|
Weighted average remaining life (in months) |
|
NM |
|
4.3 |
|
NM |
|
4.0 |
|
Weighted average prepayment speed (SMM) |
|
NM |
|
15.3
|
% |
|
NM |
|
14.0 |
% |
|
Discount rate |
|
NM |
|
14.5
|
% |
|
NM |
|
3.1 |
% |
|
Nonrecourse MSR financing liability |
|
|
|
|
|
|
|
|
|
Weighted average prepayment speed (CPR) |
|
0.8% - 9.2% |
|
5.1
|
% |
|
2.0% - 11.0% |
|
7.7 |
% |
|
Discount rate |
|
10.0% - 12.0% |
|
10.2
|
% |
|
8.1% - 10.1% |
|
9.1 |
% |
|
|
|
|
|
|
|
|
|
|
Deferred purchase price liabilities |
|
Deferred purchase price liabilities |
|
|
|
|
|
|
|
|
|
Discount rate |
|
NM |
|
8.0
|
% |
|
NM |
|
35.0% |
|
TRA obligation |
|
|
|
|
|
|
|
|
|
Discount rate |
|
NM |
|
48.3
|
% |
|
NM |
|
13.5 |
% |
|
Summary of the recognized assets and liabilities that are measured at fair value on a recurring basis |
The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2022 |
|
Total Fair Value |
|
Level 1 |
|
Level 2 |
|
Level 3 |
Assets |
|
|
|
|
|
|
|
Loans held for investment, subject to HMBS related obligations |
$ |
11,114,100
|
|
|
$ |
—
|
|
|
$ |
—
|
|
|
$ |
11,114,100
|
|
Loans held for investment, subject to nonrecourse debt: |
|
|
|
|
|
|
|
Reverse mortgage loans |
7,065,477
|
|
|
—
|
|
|
—
|
|
|
7,065,477
|
|
Fix & flip mortgage loans |
389,161
|
|
|
—
|
|
|
—
|
|
|
389,161
|
|
Loans held for investment: |
|
|
|
|
|
|
|
Reverse mortgage loans |
771,724
|
|
|
—
|
|
|
—
|
|
|
771,724
|
|
Fix & flip mortgage loans |
127,469
|
|
|
—
|
|
|
—
|
|
|
127,469
|
|
Agricultural loans |
8,805
|
|
|
—
|
|
|
—
|
|
|
8,805
|
|
Loans held for sale: |
|
|
|
|
|
|
|
Residential mortgage loans |
154,117
|
|
|
—
|
|
|
154,117
|
|
|
—
|
|
SRL |
69,187
|
|
|
—
|
|
|
—
|
|
|
69,187
|
|
Portfolio |
43,272
|
|
|
—
|
|
|
—
|
|
|
43,272
|
|
Fix and flip |
49,402
|
|
|
—
|
|
|
—
|
|
|
49,402
|
|
MSR |
95,096
|
|
|
—
|
|
|
—
|
|
|
95,096
|
|
Derivative assets: |
|
|
|
|
|
|
|
IRLCs and LPCs |
114
|
|
|
—
|
|
|
23
|
|
|
91
|
|
Forward MBS and TBAs |
1,469
|
|
|
— |
|
|
1,469
|
|
|
—
|
|
Interest rate swaps and futures contracts |
771
|
|
|
771
|
|
|
— |
|
|
—
|
|
Other assets: |
|
|
|
|
|
|
|
Purchase commitments - reverse mortgage loans |
9,356
|
|
|
—
|
|
|
—
|
|
|
9,356
|
|
Retained bonds |
46,439
|
|
|
—
|
|
|
—
|
|
|
46,439
|
|
Total assets |
$ |
19,945,959
|
|
|
$ |
771
|
|
|
$ |
155,609
|
|
|
$ |
19,789,579
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
HMBS related obligations |
$ |
10,996,755
|
|
|
$ |
—
|
|
|
$ |
—
|
|
|
$ |
10,996,755
|
|
Nonrecourse debt: |
|
|
|
|
|
|
|
Nonrecourse debt in consolidated VIE trusts |
7,175,857
|
|
|
—
|
|
|
—
|
|
|
7,175,857
|
|
Nonrecourse commercial loan financing liability |
106,758
|
|
|
—
|
|
|
—
|
|
|
106,758
|
|
Nonrecourse MSR financing liability |
60,562
|
|
|
—
|
|
|
—
|
|
|
60,562
|
|
Deferred purchase price liabilities: |
|
|
|
|
|
|
|
Deferred purchase price liabilities |
5,077
|
|
|
—
|
|
|
—
|
|
|
5,077
|
|
TRA obligation |
3,781
|
|
|
—
|
|
|
—
|
|
|
3,781
|
|
Derivative liabilities: |
|
|
|
|
|
|
|
IRLCs and LPCs |
183
|
|
|
—
|
|
|
—
|
|
|
183
|
|
Forward MBS and TBAs |
1
|
|
|
—
|
|
|
1
|
|
|
— |
|
Interest rate swaps and futures contracts |
385
|
|
|
385
|
|
|
— |
|
|
— |
|
Warrant liability |
1,117
|
|
|
1,117
|
|
|
—
|
|
|
—
|
|
Total liabilities |
$ |
18,350,476
|
|
|
$ |
1,502
|
|
|
$ |
1
|
|
|
$ |
18,348,973
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2021 |
|
Total Fair Value |
|
Level 1 |
|
Level 2 |
|
Level 3 |
Assets |
|
|
|
|
|
|
|
Loans held for investment, subject to HMBS related obligations |
$ |
10,556,054 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
10,556,054 |
|
Loans held for investment, subject to nonrecourse debt: |
|
|
|
|
|
|
|
Reverse mortgage loans |
5,823,301 |
|
|
— |
|
|
— |
|
|
5,823,301 |
|
Fix & flip mortgage loans |
394,893 |
|
|
— |
|
|
— |
|
|
394,893 |
|
Loans held for investment: |
|
|
|
|
|
|
|
Reverse mortgage loans |
940,604 |
|
|
— |
|
|
— |
|
|
940,604 |
|
Fix & flip mortgage loans |
62,933 |
|
|
— |
|
|
— |
|
|
62,933 |
|
Agricultural loans |
27,791 |
|
|
— |
|
|
— |
|
|
27,791 |
|
Loans held for sale: |
|
|
|
|
|
|
|
Residential mortgage loans |
1,902,952 |
|
|
— |
|
|
1,885,627 |
|
|
17,325 |
|
SRL |
98,852 |
|
|
— |
|
|
— |
|
|
98,852 |
|
Portfolio |
50,574 |
|
|
— |
|
|
— |
|
|
50,574 |
|
MSR |
427,942 |
|
|
— |
|
|
— |
|
|
427,942 |
|
Derivative assets: |
|
|
|
|
|
|
|
IRLCs and LPCs |
24,786 |
|
|
— |
|
|
1,564 |
|
|
23,222 |
|
Forward MBS and TBAs |
1,250 |
|
|
— |
|
|
1,250 |
|
|
— |
|
Interest rate swaps and futures contracts |
22,834 |
|
|
22,834 |
|
|
— |
|
|
— |
|
Other assets: |
|
|
|
|
|
|
|
Investments |
6,000 |
|
|
— |
|
|
— |
|
|
6,000 |
|
Retained bonds |
55,614 |
|
|
— |
|
|
— |
|
|
55,614 |
|
Total assets |
$ |
20,396,380 |
|
|
$ |
22,834 |
|
|
$ |
1,888,441 |
|
|
$ |
18,485,105 |
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
HMBS related obligations |
$ |
10,422,358 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
10,422,358 |
|
Nonrecourse debt: |
|
|
|
|
|
|
|
Nonrecourse debt in consolidated VIE trusts |
5,857,069 |
|
|
— |
|
|
— |
|
|
5,857,069 |
|
Nonrecourse commercial loan financing liability |
111,738 |
|
|
— |
|
|
— |
|
|
111,738 |
|
Nonrecourse MSR financing liability |
142,435 |
|
|
— |
|
|
— |
|
|
142,435 |
|
Deferred purchase price liabilities: |
|
|
|
|
|
|
|
Deferred purchase price liabilities |
12,852 |
|
|
— |
|
|
— |
|
|
12,852 |
|
TRA obligation |
29,380 |
|
|
— |
|
|
— |
|
|
29,380 |
|
Derivative liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward MBS and TBAs |
1,685 |
|
|
— |
|
|
1,685 |
|
|
— |
|
Interest rate swaps and futures contracts |
24,993 |
|
|
24,993 |
|
|
— |
|
|
— |
|
Warrant liability |
5,497 |
|
|
5,497 |
|
|
— |
|
|
— |
|
Total liabilities |
$ |
16,608,007 |
|
|
$ |
30,490 |
|
|
$ |
1,685 |
|
|
$ |
16,575,832 |
|
|
Fair value, assets measured on recurring basis, unobservable input reconciliation |
Assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3, in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Successor |
|
Assets |
Year ended December 31, 2022 |
Loans held for investment |
|
Loans held for investment, subject to nonrecourse debt |
|
Loans held for sale |
|
Derivative assets |
|
MSR |
|
Retained bonds |
|
Purchase commitments |
|
Investments |
Beginning balance |
$ |
11,587,382
|
|
|
$ |
6,218,194
|
|
|
$ |
166,751
|
|
|
$ |
23,222
|
|
|
$ |
427,942
|
|
|
$ |
55,614
|
|
|
$ |
—
|
|
|
$ |
6,000
|
|
Total gain or losses included in earnings |
190,714
|
|
|
(744,123) |
|
|
(15,213) |
|
|
(23,131) |
|
|
22,989
|
|
|
(8,668) |
|
|
9,356
|
|
|
(6,000) |
|
Purchases, settlements, and transfers: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases and additions, net |
6,165,003
|
|
|
117,010
|
|
|
1,119,578
|
|
|
—
|
|
|
122,362
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Sales and settlements |
(2,178,245) |
|
|
(1,847,648) |
|
|
(1,103,492) |
|
|
—
|
|
|
(478,197) |
|
|
(507) |
|
|
—
|
|
|
—
|
|
Transfers in/(out) between categories |
(3,742,756) |
|
|
3,711,205
|
|
|
(5,763) |
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Ending balance |
$ |
12,022,098
|
|
|
$ |
7,454,638
|
|
|
$ |
161,861
|
|
|
$ |
91
|
|
|
$ |
95,096
|
|
|
$ |
46,439
|
|
|
$ |
9,356
|
|
|
$ |
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Successor |
|
Assets |
Nine months ended December 31, 2021 |
Loans held for investment |
|
Loans held for investment, subject to nonrecourse debt |
|
Loans held for sale |
|
Derivative assets |
|
MSR |
|
Retained Bonds |
|
Investments |
Beginning balance |
$ |
11,171,736 |
|
|
$ |
5,291,444 |
|
|
$ |
135,681 |
|
|
$ |
38,574 |
|
|
$ |
267,364 |
|
|
$ |
— |
|
|
$ |
9,470 |
|
Total gain or losses included in earnings |
272,802 |
|
|
71,126 |
|
|
1,214 |
|
|
(14,217) |
|
|
(15,200) |
|
|
1,344 |
|
|
(3,470) |
|
Purchases, settlements, and transfers: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases and additions, net |
4,438,629 |
|
|
80,542 |
|
|
915,522 |
|
|
— |
|
|
178,279 |
|
|
54,752 |
|
|
— |
|
Sales and settlements |
(2,235,651) |
|
|
(1,275,674) |
|
|
(894,494) |
|
|
(1,135) |
|
|
(2,501) |
|
|
(482) |
|
|
— |
|
Transfers in/(out) between categories |
(2,060,134) |
|
|
2,050,756 |
|
|
8,828 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Ending balance |
$ |
11,587,382 |
|
|
$ |
6,218,194 |
|
|
$ |
166,751 |
|
|
$ |
23,222 |
|
|
$ |
427,942 |
|
|
$ |
55,614 |
|
|
$ |
6,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor |
|
Assets |
Three months ended March 31, 2021 |
Loans held for investment |
|
Loans held for investment, subject to nonrecourse debt |
|
Loans held for sale |
|
Derivative assets |
|
MSR |
|
Investments |
Beginning balance |
$ |
10,659,984 |
|
|
$ |
5,396,167 |
|
|
$ |
152,854 |
|
|
$ |
88,660 |
|
|
$ |
180,684 |
|
|
$ |
18,934 |
|
Total gain or losses included in earnings |
132,499 |
|
|
(37,757) |
|
|
2,764 |
|
|
(50,040) |
|
|
20,349 |
|
|
(9,464) |
|
Purchases, settlements, and transfers: |
|
|
|
|
|
|
|
|
|
|
|
Purchases and additions, net |
1,143,109 |
|
|
21,064 |
|
|
175,551 |
|
|
— |
|
|
74,978 |
|
|
— |
|
Sales and settlements |
(534,738) |
|
|
(360,128) |
|
|
(152,579) |
|
|
(46) |
|
|
(8,647) |
|
|
— |
|
Transfers in/(out) between categories |
(229,118) |
|
|
272,098 |
|
|
(42,909) |
|
|
— |
|
|
— |
|
|
— |
|
Ending balance |
$ |
11,171,736 |
|
|
$ |
5,291,444 |
|
|
$ |
135,681 |
|
|
$ |
38,574 |
|
|
$ |
267,364 |
|
|
$ |
9,470 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor |
|
Assets |
For the year ended December 31, 2020 |
Loans held for investment |
|
Loans held for investment, subject to nonrecourse debt |
|
Loans held for sale |
|
Derivative assets |
|
MSR |
|
Debt Securities |
|
Investments |
Beginning balance |
$ |
10,894,577 |
|
|
$ |
3,511,212 |
|
|
$ |
182,973 |
|
|
$ |
14,008 |
|
|
$ |
2,600 |
|
|
$ |
102,260 |
|
|
$ |
20,508 |
|
Total gain or losses included in earnings |
627,251 |
|
|
304,663 |
|
|
(2,158) |
|
|
74,470 |
|
|
4,562 |
|
|
2,288 |
|
|
(5,512) |
|
Purchases, settlements, and transfers: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases and additions, net |
3,616,667 |
|
|
136,838 |
|
|
409,467 |
|
|
182 |
|
|
173,522 |
|
|
24,489 |
|
|
3,938 |
|
Sales and settlements |
(1,536,977) |
|
|
(1,285,902) |
|
|
(605,018) |
|
|
— |
|
|
— |
|
|
(129,037) |
|
|
— |
|
Transfers in/(out) between categories |
(2,941,534) |
|
|
2,729,356 |
|
|
167,590 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Ending balance |
$ |
10,659,984 |
|
|
$ |
5,396,167 |
|
|
$ |
152,854 |
|
|
$ |
88,660 |
|
|
$ |
180,684 |
|
|
$ |
— |
|
|
$ |
18,934 |
|
|
Fair value, liabilities measured on recurring basis, unobservable input reconciliation |
Assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3, in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Successor |
|
Liabilities |
Year ended December 31, 2022 |
HMBS related obligations |
|
|
|
Deferred purchase price liabilities |
|
|
|
Nonrecourse debt in consolidated VIE trusts |
|
Nonrecourse commercial loan financing liability |
|
Nonrecourse MSR financing liability |
|
TRA Liability |
Beginning balance |
$ |
(10,422,358) |
|
|
|
|
$ |
(12,852) |
|
|
|
|
$ |
(5,857,069) |
|
|
$ |
(111,738) |
|
|
$ |
(142,435) |
|
|
$ |
(29,380) |
|
Total gain or losses included in earnings |
(29,015) |
|
|
|
|
—
|
|
|
|
|
316,963
|
|
|
2,527
|
|
|
(8,162) |
|
|
25,599
|
|
Purchases, settlements, and transfers: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases and additions, net |
(2,870,650) |
|
|
|
|
—
|
|
|
|
|
(3,202,519) |
|
|
(205,746) |
|
|
(14,196) |
|
|
—
|
|
Settlements |
2,325,268
|
|
|
|
|
7,775
|
|
|
|
|
1,566,768
|
|
|
208,199
|
|
|
104,231
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance |
$ |
(10,996,755) |
|
|
|
|
$ |
(5,077) |
|
|
|
|
$ |
(7,175,857) |
|
|
$ |
(106,758) |
|
|
$ |
(60,562) |
|
|
$ |
(3,781) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Successor |
|
Liabilities |
Nine months ended December 31, 2021 |
HMBS related obligations |
|
Derivative liabilities |
|
Deferred purchase price liabilities |
|
Nonrecourse debt in consolidated VIE trusts |
|
Nonrecourse commercial loan financing liability |
|
Nonrecourse MSR financing liability |
|
TRA Liability |
Beginning balance |
$ |
(9,926,132) |
|
|
$ |
(936) |
|
|
$ |
(3,214) |
|
|
$ |
(5,205,892) |
|
|
$ |
— |
|
|
$ |
(22,051) |
|
|
$ |
— |
|
Total gain or losses included in earnings |
62,306 |
|
|
(98) |
|
|
(2,240) |
|
|
(74,333) |
|
|
1,019 |
|
|
(2,998) |
|
|
2,570 |
|
Purchases, settlements, and transfers: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases and additions, net |
(2,491,919) |
|
|
— |
|
|
(7,984) |
|
|
(1,813,458) |
|
|
(176,863) |
|
|
(117,386) |
|
|
(31,950) |
|
Settlements |
1,933,387 |
|
|
1,034 |
|
|
586 |
|
|
1,236,614 |
|
|
64,106 |
|
|
— |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance |
$ |
(10,422,358) |
|
|
$ |
— |
|
|
$ |
(12,852) |
|
|
$ |
(5,857,069) |
|
|
$ |
(111,738) |
|
|
$ |
(142,435) |
|
|
$ |
(29,380) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor |
|
Liabilities |
Three months ended March 31, 2021 |
HMBS related obligations |
|
|
|
Derivative liabilities |
|
Deferred purchase price liability |
|
Nonrecourse debt in consolidated VIE trusts |
|
Nonrecourse MSR financing liability |
|
|
|
|
Beginning balance |
$ |
(9,788,668) |
|
|
|
|
$ |
(1,084) |
|
|
$ |
(3,842) |
|
|
$ |
(5,257,754) |
|
|
$ |
(14,088) |
|
|
|
|
|
Total gain or losses included in earnings |
(41,434) |
|
|
|
|
— |
|
|
(29) |
|
|
(30,770) |
|
|
390 |
|
|
|
|
|
Purchases, settlements, and transfers: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases and additions, net |
(602,172) |
|
|
|
|
— |
|
|
— |
|
|
(575,668) |
|
|
(8,353) |
|
|
|
|
|
Settlements |
506,142 |
|
|
|
|
148 |
|
|
657 |
|
|
658,300 |
|
|
— |
|
|
|
|
|
Ending balance |
$ |
(9,926,132) |
|
|
|
|
$ |
(936) |
|
|
$ |
(3,214) |
|
|
$ |
(5,205,892) |
|
|
$ |
(22,051) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor |
|
Liability |
For the year ended December 31, 2020 |
HMBS related obligations |
|
Derivative liabilities |
|
Deferred purchase price liabilities |
|
Nonrecourse debt in consolidated VIE trusts |
|
Nonrecourse MSR financing liability |
Beginning balance |
$ |
(9,320,209) |
|
|
$ |
(68) |
|
|
$ |
(4,300) |
|
|
$ |
(3,490,196) |
|
|
$ |
— |
|
Total gain or losses included in earnings |
(359,951) |
|
|
(834) |
|
|
(3,014) |
|
|
(294,802) |
|
|
798 |
|
Purchases, settlements, and transfers: |
|
|
|
|
|
|
|
|
|
Purchases and additions, net |
(2,051,953) |
|
|
(182) |
|
|
(138) |
|
|
(3,110,368) |
|
|
(15,101) |
|
Settlements |
1,943,445 |
|
|
— |
|
|
3,610 |
|
|
1,637,612 |
|
|
215 |
|
|
|
|
|
|
|
|
|
|
|
Ending balance |
$ |
(9,788,668) |
|
|
$ |
(1,084) |
|
|
$ |
(3,842) |
|
|
$ |
(5,257,754) |
|
|
$ |
(14,088) |
|
|
Summary of the fair value and unpaid principal balance ("UPB") |
Presented in the tables below are the fair value and UPB, at December 31, 2022 and December 31, 2021, of financial assets and liabilities for which the Company has elected the fair value option (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2022 |
|
Estimated Fair Value |
|
Unpaid Principal Balance |
Assets at fair value under the fair value option |
|
|
|
|
Loans held for investment, subject to HMBS related obligations |
|
$ |
11,114,100
|
|
|
$ |
10,719,000
|
|
Loans held for investment, subject to nonrecourse debt: |
|
|
|
|
Reverse mortgage loans |
|
7,065,477
|
|
|
7,240,125
|
|
Commercial mortgage loans |
|
389,161
|
|
|
405,970
|
|
Loans held for investment: |
|
|
|
|
Reverse mortgage loans |
|
771,724
|
|
|
724,800
|
|
Commercial mortgage loans |
|
136,274
|
|
|
143,373
|
|
Loans held for sale: |
|
|
|
|
Residential mortgage loans |
|
154,117
|
|
|
167,407
|
|
Commercial mortgage loans |
|
161,861
|
|
|
173,112
|
|
Other assets: |
|
|
|
|
Purchase commitments - reverse mortgage loans |
|
9,356
|
|
|
9,356
|
|
Liabilities at fair value under the fair value option |
|
|
|
|
HMBS related obligations |
|
10,996,755
|
|
|
10,719,000
|
|
Nonrecourse debt: |
|
|
|
|
Nonrecourse debt in consolidated VIE trusts |
|
7,175,857
|
|
|
7,819,992
|
|
Nonrecourse MSR financing liability |
|
60,562
|
|
|
60,562
|
|
Nonrecourse commercial loan financing liability |
|
106,758
|
|
|
105,291
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2021 |
|
Estimated Fair Value |
|
Unpaid Principal Balance |
Assets at fair value under the fair value option |
|
|
|
|
Loans held for investment, subject to HMBS related obligations |
|
$ |
10,556,054 |
|
|
$ |
9,849,835 |
|
Loans held for investment, subject to nonrecourse debt: |
|
|
|
|
Reverse mortgage loans |
|
5,823,301 |
|
|
5,165,479 |
|
Commercial mortgage loans |
|
394,893 |
|
|
388,788 |
|
Loans held for investment: |
|
|
|
|
Reverse mortgage loans |
|
940,604 |
|
|
815,426 |
|
Commercial mortgage loans |
|
90,724 |
|
|
89,267 |
|
Loans held for sale: |
|
|
|
|
Residential mortgage loans |
|
1,902,952 |
|
|
1,859,788 |
|
Commercial mortgage loans |
|
149,426 |
|
|
145,463 |
|
Liabilities at fair value under the fair value option |
|
|
|
|
HMBS related obligations |
|
10,422,358 |
|
|
9,849,835 |
|
Nonrecourse debt: |
|
|
|
|
Nonrecourse debt in consolidated VIE trusts |
|
5,857,069 |
|
|
5,709,946 |
|
Nonrecourse MSR financing liability |
|
142,435 |
|
|
142,435 |
|
Nonrecourse commercial loan financing liability |
|
111,738 |
|
|
107,744 |
|
|
Summary of the components of net fair value gains on mortgage loans and related obligations |
Provided in the table below is a summary of the components of net fair value gains on loans and related obligations (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, 2022 |
|
|
|
For the nine months ended December 31, 2021 |
|
|
For the three months ended March 31, 2021 |
|
For the year ended December 31, 2020 |
|
|
|
|
|
|
Successor |
|
|
Predecessor |
|
|
|
Net fair value gains on loans and related obligations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income on reverse and commercial loans |
|
|
$ |
857,271
|
|
|
|
|
$ |
495,163 |
|
|
|
$ |
160,568 |
|
|
$ |
709,679 |
|
|
|
|
Change in fair value of loans |
|
|
(1,365,798) |
|
|
|
|
(108,860) |
|
|
|
(51,346) |
|
|
296,676 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net fair value gains (losses) on loans |
|
|
(508,527) |
|
|
|
|
386,303 |
|
|
|
109,222 |
|
|
1,006,355 |
|
|
|
|
Interest expense on HMBS and nonrecourse obligations |
|
|
(560,316) |
|
|
|
|
(329,344) |
|
|
|
(119,201) |
|
|
(526,690) |
|
|
|
|
Change in fair value of derivatives |
|
|
332,630
|
|
|
|
|
(28,233) |
|
|
|
43,972 |
|
|
(12,482) |
|
|
|
|
Change in fair value of related obligations |
|
|
840,407
|
|
|
|
|
313,024 |
|
|
|
42,670 |
|
|
(155,485) |
|
|
|
|
Net fair value gains (losses) on related obligations |
|
|
612,721
|
|
|
|
|
(44,553) |
|
|
|
(32,559) |
|
|
(694,657) |
|
|
|
|
Net fair value gains on loans and related obligations |
|
|
$ |
104,194
|
|
|
|
|
$ |
341,750 |
|
|
|
$ |
76,663 |
|
|
$ |
311,698 |
|
|
|
|
|